Anti-neutrophil extracellular trap antibody in a patient with relapse of anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report
- PMID: 29929470
- PMCID: PMC6013953
- DOI: 10.1186/s12882-018-0953-y
Anti-neutrophil extracellular trap antibody in a patient with relapse of anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report
Abstract
Background: Neutrophil extracellular traps (NETs) are web-like DNA decorated with antimicrobial proteins, such as myeloperoxidase (MPO), which are extruded from activated neutrophils. Although NETs are essential in innate immunity, an excessive formation of NETs has adverse effects, e.g., induction of anti-neutrophil cytoplasmic antibody (ANCA), to the hosts. Since ANCA can induce NET formation in the primed neutrophils, a positive feedback loop can be formed between NETs and ANCA, which is called "ANCA-NETs vicious cycle."
Case presentation: A 79-year-old Japanese woman developed hydralazine-induced pauci-immune necrotizing crescentic glomerulonephritis with MPO-ANCA. Although the illness improved after cessation of hydralazine, MPO-ANCA-associated vasculitis relapsed 16 months later. Remission was achieved 5 months after beginning of administration of prednisone. In order to determine the involvement of ANCA-NETs vicious cycle in this patient, we examined NET degradation and induction activities in sera obtained at the disease onset (Serum A; MPO-ANCA, 107 IU/ml), at relapse (Serum B; MPO-ANCA, 195 IU/ml), at 3 months after treatment (Serum C; MPO-ANCA, 4.5 IU/ml), and at remission (Serum D; MPO-ANCA, 2.4 IU/ml). NET degradation activity was low in the all sera. NET induction activity was high in Sera A, B, and C but not in D. Additionally, we demonstrated the presence of anti-NET antibody (ANETA) in Sera B and C but not in A or D.
Conclusions: The collective findings suggest NET induction potential of ANETA in the present patient and that the ANETA could contribute to the enhancement of NETs resulting in amplification of the ANCA-NETs vicious cycle.
Keywords: ANCA-NETs vicious cycle; ANCA-associated vasculitis (AAV); Anti-NET antibody (ANETA); Neutrophil extracellular traps (NETs).
Conflict of interest statement
Ethics approval and consent to participate
This study was approved by the Ethical Committee of Osaka General Medical Center (Permission No. 29-C0313) and the Ethical Committee of Faculty of Health Sciences, Hokkaido University (Permission No. 15–90). The patient gave informed consent for participation of this study.
Consent for publication
The patient gave informed consent for publication of data.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures


Similar articles
-
The presence of anti-neutrophil extracellular trap antibody in patients with microscopic polyangiitis.Rheumatology (Oxford). 2019 Jul 1;58(7):1293-1298. doi: 10.1093/rheumatology/kez089. Rheumatology (Oxford). 2019. PMID: 30897615
-
Myeloperoxidase anti-neutrophil cytoplasmic antibody affinity is associated with the formation of neutrophil extracellular traps in the kidney and vasculitis activity in myeloperoxidase anti-neutrophil cytoplasmic antibody-associated microscopic polyangiitis.Nephrology (Carlton). 2016 Jul;21(7):624-9. doi: 10.1111/nep.12736. Nephrology (Carlton). 2016. PMID: 26833773 Free PMC article.
-
Excessive neutrophil extracellular trap formation in ANCA-associated vasculitis is independent of ANCA.Kidney Int. 2018 Jul;94(1):139-149. doi: 10.1016/j.kint.2018.01.013. Epub 2018 Mar 30. Kidney Int. 2018. PMID: 29606398
-
Neutrophil Extracellular Traps in ANCA-Associated Vasculitis.Front Immunol. 2016 Jun 30;7:256. doi: 10.3389/fimmu.2016.00256. eCollection 2016. Front Immunol. 2016. PMID: 27446086 Free PMC article. Review.
-
Neutrophil Extracellular Traps: A Potential Therapeutic Target in MPO-ANCA Associated Vasculitis?Front Immunol. 2021 Mar 15;12:635188. doi: 10.3389/fimmu.2021.635188. eCollection 2021. Front Immunol. 2021. PMID: 33790907 Free PMC article. Review.
Cited by
-
Hydralazine-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Asymptomatic and Renal-Restricted Presentation.Am J Case Rep. 2021 May 16;22:e931263. doi: 10.12659/AJCR.931263. Am J Case Rep. 2021. PMID: 33993184 Free PMC article.
-
Low disease activity of microscopic polyangiitis in patients with anti-myosin light chain 6 antibody that disrupts actin rearrangement necessary for neutrophil extracellular trap formation.Arthritis Res Ther. 2022 Dec 16;24(1):274. doi: 10.1186/s13075-022-02974-9. Arthritis Res Ther. 2022. PMID: 36527167 Free PMC article.
-
Overlapping Syndromes: Drug-Induced Vasculitis From Hydralazine With Positive Antinuclear Antibodies.Clin Med Insights Case Rep. 2023 Jan 11;16:11795476221146906. doi: 10.1177/11795476221146906. eCollection 2023. Clin Med Insights Case Rep. 2023. PMID: 36643285 Free PMC article.
-
Narrative Review of Hypercoagulability in Small-Vessel Vasculitis.Kidney Int Rep. 2020 Jan 13;5(5):586-599. doi: 10.1016/j.ekir.2019.12.018. eCollection 2020 May. Kidney Int Rep. 2020. PMID: 32405580 Free PMC article. Review.
-
The role of neutrophils in rheumatic disease-associated vascular inflammation.Nat Rev Rheumatol. 2022 Mar;18(3):158-170. doi: 10.1038/s41584-021-00738-4. Epub 2022 Jan 17. Nat Rev Rheumatol. 2022. PMID: 35039664 Review.
References
-
- Schreiber A, Rousselle A, Becker JU, von Massenhausen A, Linkermann A, Kettritz R. Necroptosis controls NET generation and mediates complement activation, endothelial damage, and autoimmune vasculitis. Proc Natl Acad Sci U S A. 2017;114(45):E9618–E9625. doi: 10.1073/pnas.1708247114. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous